4.7 Review

An updated multifaceted overview of sweet proteins and dipeptides as sugar substitutes; the chemistry, health benefits, gut interactions, and safety

期刊

FOOD RESEARCH INTERNATIONAL
卷 162, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.foodres.2022.111853

关键词

Dipeptide sweeteners; Sweet proteins; Chemistry; Safety; Applications; Metabolism; Phenylketonuria (PKU)

资金

  1. Swedish Research Council Veten-skapsrdet [2016-05885]
  2. National Natural Science Foundation of China [32172791]

向作者/读者索取更多资源

Artificial sweeteners are popular worldwide due to their lower calorie content and potential health benefits. However, their safety remains controversial. This review focuses on low-calorie protein/peptide sweeteners, comparing synthetic and natural sweeteners, and presenting their health benefits and safety in terms of metabolic profiles and gut interaction.
Artificial sweeteners have become increasingly popular worldwide owing to their lower calorie content in addition to the claims of health benefits such as weight control, blood glucose level regulation in diabetics, and protection against dental caries. Nevertheless, there is still controversy regarding their safety, especially when administered over the long term, taking into account that most of the safety studies are based on animal models and only a few human studies. This review focuses on low-calorie protein/peptide sweeteners. These include artificial sweeteners, i.e. aspartame, advantame, neotame, and alitame which are synthetic, versus those of natural origin such as thaumatin, monellin, brazzein, pentadin, mabinlin, curculin, and egg white lysozyme. We conducted a systematic literature survey to ensure the accuracy of the data regarding the chemical properties, synthesis, and industrial applications. The health benefits and safety of these sweeteners in humans are presented for the first time in context to their metabolic profiles and gut interaction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据